Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT00986609
What this trial is testing

MUC1 Vaccine for Triple-negative Breast Cancer

Who this might be right for
Breast CancerInflammatory Breast CancerStage I Breast Cancer+5 more
Joseph Baar, MD, PhD 29
Early research (Phase 1)Ended earlyNCT06052852
What this trial is testing

Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies

Who this might be right for
Triple Negative Breast CancerClear Cell Renal Cell CarcinomaOvarian Cancer+4 more
Bolt Biotherapeutics, Inc. 17
Testing effectiveness (Phase 2)Ended earlyNCT02362230
What this trial is testing

Evaluation of Icotinib in Metastatic Triple-negative Breast Cancer After Second-line Therapy

Who this might be right for
Metastatic Breast Cancer
Sun Yat-sen University 26
Testing effectiveness (Phase 2)UnknownNCT00491816
What this trial is testing

Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
University of Kansas Medical Center 32
Early research (Phase 1)Study completedNCT01104259
What this trial is testing

Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerHereditary Breast/Ovarian Cancer - BRCA1+6 more
University of Washington 50
Very early researchWithdrawnNCT05957042
What this trial is testing

Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).

Who this might be right for
Breast CancerContrast Enhanced Ultrasound
Milton S. Hershey Medical Center
Not applicableStudy completedNCT03981705
What this trial is testing

Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer

Who this might be right for
TN ER-/PR-/HER2- Breast CancerTriple Negative Breast CancerHER2-positive Breast Cancer+1 more
Masonic Cancer Center, University of Minnesota 8
Early research (Phase 1)WithdrawnNCT02627430
What this trial is testing

Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer

Who this might be right for
Adult Solid NeoplasmEstrogen Receptor NegativeFallopian Tube Serous Neoplasm+10 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00472693
What this trial is testing

Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 5
Very early researchLooking for participantsNCT05341492
What this trial is testing

EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer

Who this might be right for
EGFR/ B7H3-positive Advanced Lung CancerEGFR/ B7H3-positive Advanced Triple-negative Breast Cancer
Second Affiliated Hospital of Guangzhou Medical University 30
Early research (Phase 1)Looking for participantsNCT05768932
What this trial is testing

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Advanced Solid TumorTNBC - Triple-Negative Breast CancerGastric Cancer+1 more
SillaJen, Inc. 260
Testing effectiveness (Phase 2)Study completedNCT05112536
What this trial is testing

Trilaciclib, a CDK4/6 Inhibitor, in Patients With Early-Stage Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerBreast Cancer
G1 Therapeutics, Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT06851299
What this trial is testing

The Clinical Study of the Efficacy and Safety of Trop2-ADC Monotherapy or Combination Immunotherapy Strategy in the Treatment of Advanced Triple-negative Breast Cancer.

Who this might be right for
Metastatic Triple-negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 60
Early research (Phase 1)Study completedNCT01451632
What this trial is testing

A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers

Who this might be right for
Colorectal CancerSquamous Cell Head and Neck CancerNon-small Cell Lung Cancer+2 more
Merrimack Pharmaceuticals 48
Testing effectiveness (Phase 2)Looking for participantsNCT05749588
What this trial is testing

FUSCC Refractory TNBC Platform Study (FUTURE2.0)

Who this might be right for
Triple-negative Breast Cancer
Fudan University 120
Early research (Phase 1)Looking for participantsNCT05403554
What this trial is testing

NI-1801 in Patients with Mesothelin Expressing Solid Cancers

Who this might be right for
Epithelial Ovarian CancerTriple Negative Breast CancerNon-squamous Non-small-cell Lung Cancer+2 more
Light Chain Bioscience - Novimmune SA 70
Large-scale testing (Phase 3)Looking for participantsNCT06841354
What this trial is testing

Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Who this might be right for
Triple Negative Breast Neoplasms
Merck Sharp & Dohme LLC 1,000
Not applicableStudy completedNCT02850302
What this trial is testing

Triple Negative Breast Cancer: Identification Pilot Study of Predictive Transcriptome Profiles of Early Tumor Drug Resistance Observed in 18F-Fluorodeoxyglucose (FDG) PET

Who this might be right for
Breast Neoplasms
Centre Georges Francois Leclerc 23
Large-scale testing (Phase 3)Not Yet RecruitingNCT07723469
What this trial is testing

Phase 3 Trial of SRG-514 Administered Intraoperatively to Patients Undergoing Breast-Conserving Surgery

Who this might be right for
TNBC - Triple-Negative Breast Cancer
SURGE Therapeutics 400
Early research (Phase 1)Ended earlyNCT03746431
What this trial is testing

[225Ac]-FPI-1434 Injection

Who this might be right for
Advanced Solid TumoursEndometrial CancerCervical Cancer+7 more
Fusion Pharmaceuticals Inc. 78
Next Page